The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
Abstract
Cholinergic synapses are ubiquitous in the human central nervous system. Their high density in the thalamus, striatum, limbic system, and neocortex suggest that cholinergic transmission is likely to be critically important for memory, learning, attention and other higher brain functions. Several lines of research suggest additional roles for cholinergic systems in overall brain homeostasis and plasticity. As such, the brain's cholinergic system occupies a central role in ongoing research related to normal cognition and age-related cognitive decline, including dementias such as Alzheimer's disease. The cholinergic hypothesis of Alzheimer's disease centres on the progressive loss of limbic and neocortical cholinergic innervation. Neurofibrillary degeneration in the basal forebrain is believed to be the primary cause for the dysfunction and death of forebrain cholinergic neurons, giving rise to a widespread presynaptic cholinergic denervation. Cholinesterase inhibitors increase the availability of acetylcholine at synapses in the brain and are one of the few drug therapies that have been proven clinically useful in the treatment of Alzheimer's disease dementia, thus validating the cholinergic system as an important therapeutic target in the disease. This review includes an overview of the role of the cholinergic system in cognition and an updated understanding of how cholinergic deficits in Alzheimer's disease interact with other aspects of disease pathophysiology, including plaques composed of amyloid-β proteins. This review also documents the benefits of cholinergic therapies at various stages of Alzheimer's disease and during long-term follow-up as visualized in novel imaging studies. The weight of the evidence supports the continued value of cholinergic drugs as a standard, cornerstone pharmacological approach in Alzheimer's disease, particularly as we look ahead to future combination therapies that address symptoms as well as disease progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FDA approved two anti-amyloid immunotherapies, lecanemab and donanemab, for “early-stage” AD, encompassing both stage 3 (MCI) and stage 4 (mild dementia).”
From A 2025 update on treatment strategies for the Alzheimer’s disease spectrum (2025) · cites this paper as [18]
In the citing paper
“Degeneration of cholinergic neurons is known to significantly contribute to cognitive decline in AD patients [132] and has been studied in a variety of genetic AD mouse models.”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [132]
In the citing paper
“AChE contributes to acetylcholine depletion and may facilitate the formation of neurotoxic Aβ-AChE complexes38.”
From Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses microglial inflammation in Alzheimer’s disease models (2026) · cites this paper as [38]
In the citing paper
“Cholinergic deficit also alters the permeability of the blood brain barrier causing erroneous transportation of metabolites and hampering the removal of amyloid plaque, worsening the disease condition [8].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [8]
In the citing paper
“From this point of view, AD could be prevented or effectively treated by decreasing the production of Aβ and tau; preventing aggregation or misfolding of these proteins; neutralizing or removing the toxic aggregate or misfolded forms of these proteins; or a combination of these modalities.7”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [7]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Research works printed but not linked: 1
- Geula, 1994, Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease, 263
Cited by
Items 401–500 of 1,002
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., García‐León, J. A., Nuñez‐Diaz, C., Dávila, J. C., Vitórica, J., LaFerla, F. M., Moreno‐González, I., Gutiérrez, A., et al. (2021) · The Neuroscientist · doi:10.1177/10738584211001753 · Cited by 30
Gonzalez, S., McHugh, T. L. M., Yang, T., Syriani, W., Massa, S. M., Longo, F. M., & Simmons, D. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105563 · Cited by 30
Zhao, X., Wang, S., & Sun, W. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8920 · Cited by 30
Kelley, C. M., Ginsberg, S. D., Alldred, M. J., Strupp, B. J., & Mufson, E. J. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22700 · Cited by 31
Mitra, S., Gera, R., Linderoth, B., Lind, G., Wahlberg, L. U., Almqvist, P. M., Behbahani, H., & Eriksdotter, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74046-7_11 · Cited by 30
Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Sun, Y.-Y., Wang, Z., Zhou, H.-Y., & Huang, H. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00097 · Cited by 30
Duggal, P., & Mehan, S. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190125 · Cited by 30
Differential response to donepezil in MRI subtypes of mild cognitive impairment
Diaz‐Galvan, P., Lorenzon, G., Mohanty, R., Mårtensson, G., Cavedo, E., Lista, S., Vergallo, A., Kantarci, K., Hampel, H. J., Dubois, B., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01253-2 · Cited by 30
Self-citationNizari, S., Carare, R. O., Romero, I. A., & Hawkes, C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00172 · Cited by 30
Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer’s Disease
Yu, D., Wang, L., Kong, D., & Zhu, H. (2022) · Journal of the American Statistical Association · doi:10.1080/01621459.2022.2087658 · Cited by 32
Mani, V., Rabbani, S. I., Shariq, A., Amirthalingam, P., & Arfeen, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121563 · Cited by 30
Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy
Almohmadi, N. H., Al-Kuraishy, H. M., Albuhadily, A. K., Al-Gareeb, A. I., Abdelaziz, A. M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103639 · Cited by 30
Prajjwal, P., Asharaf, S., Makhanasa, D., Yamparala, A., Tariq, H., Aleti, S., Gadam, S., & Vora, N. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101546 · Cited by 30
Pang, B., Zhang, L., Li, B., Sun, F.-X., & Wang, Z. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114134 · Cited by 30
Pan, S., Yang, P. H., DeFreitas, D., Ramagiri, S., Bayguinov, P. O., Hacker, C. D., Snyder, A. Z., Wilborn, J., Huang, H., Koller, G. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36083-1 · Cited by 30
Sang, Z., Bai, P., Ban, Y., Wang, K., Wu, A., Mi, J., Hu, J., Xu, R., Zhu, G., Wang, J., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106007 · Cited by 30
Honorio, P., Sainimnuan, S., Hannongbua, S., & Saparpakorn, P. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109523 · Cited by 30
Miao, S., He, Q., Li, C., Wu, Y., Liu, M., Chen, Y., Qi, S., & Gong, K. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2102657 · Cited by 29
“Many studies have revealed that AChE and BuChE are key players involved in the pathology of AD and may serve as potential therapeutic targets (Hampel et al. 2018).”
BackgroundKoulousakis, P., Andrade, P., Visser-Vandewalle, V. E. R. M., & Sesia, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180133 · Cited by 29
CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
Chacko, L., Chaudhary, A., Singh, B., Dewanjee, S., & Kandimalla, R. J. L. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103652 · Cited by 29
Castañeda, A., Ferraz, R., Vieira, M., Cardoso, I., Vasconcelos, V. M., & Martins, R. F. (2021) · Marine Drugs · doi:10.3390/md19060343 · Cited by 29
Kim, C. J., Ryu, H. Y., Lee, S., Han-Joo, L., Chun, Y. S., Kim, J., Yu, C.-Y., Ghimire, B. K., & Lee, J. G. (2021) · Molecules · doi:10.3390/molecules26103001 · Cited by 29
Dobryakova, Y. V., Volobueva, M. N., Манолова, А. О., Medvedeva, T. M., Kvichansky, A. A., Gulyaeva, N. V., Markevich, V. A., Stepanichev, M. Y., & Bolshakov, A. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00146 · Cited by 29
Amenotie, A. J., Ben‐Azu, B., Esuku, D. T., Chijioke, B. S., Abo, E., Ozah, E. O., Lawrence, E. O., Efejene, I. O., Onyeukwu, O. B., Alabi, B. A., et al. (2025) · Neurotoxicity Research · doi:10.1007/s12640-025-00750-6 · Cited by 29
Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease
Lao, K., Zhang, R., Luan, J., Zhang, Y., & Gou, X. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200851 · Cited by 29
Macht, V. A., Vetreno, R. P., Elchert, N., & Crews, F. T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02243-7 · Cited by 29
Dihydropyrimidinone-derived selenoesters efficacy and safety in an in vivo model of Aβ aggregation
Pereira, F. S. D. O., Barbosa, F. A. R., Canto, R. F. S., Luchese, C., Pinton, S., Braga, A. L., de Azeredo, J. B., Quines, C. B., & Ávila, D. S. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.10.012 · Cited by 29
Pruthi, S., Kaur, K., Singh, V., & Shri, R. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00687-7 · Cited by 28
Zhang, B., Zhao, J., Wang, Z., Guo, P., Liu, A., & Du, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709607 · Cited by 28
Xie, Q., Hu, X., Zhao, X., Xiang, Z., Chen, Q., Xie, Z., Wang, H., Zhao, Y., Cheng, X. M., & Wang, C. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117106 · Cited by 28
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle
Morris, J. K., McCoin, C. S., Fuller, K. N. Z., John, C. S., Wilkins, H., Green, Z. D., Wang, X., Sharma, P., Burns, J. M., Vidoni, E. D., et al. (2021) · Function · doi:10.1093/function/zqab045 · Cited by 28
Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia
Pluta, R. M., Furmaga-Jabłońska, W., Januszewski, S., & Tarkowska, A. (2023) · Molecules · doi:10.3390/molecules28031105 · Cited by 28
Maříková, J., Ritomská, A., Korábečný, J., Peřinová, R., Mamun, A. A., Kučera, T., Kohelová, E., Hulcová, D., Kobrlová, T., Kuneš, J., et al. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00561 · Cited by 28
EEG frequency bands in subjective cognitive decline: A systematic review of resting state studies
Pérez, V., Duque, A., Hidalgo, V., & Salvador, A. (2024) · Biological Psychology · doi:10.1016/j.biopsycho.2024.108823 · Cited by 28
Tran, T., Vo, T.-T.-H., Vo, T.-Q.-N., Cao, T., & Tran, T. (2021) · The Scientific World JOURNAL · doi:10.1155/2021/4817900 · Cited by 28
REM sleep is associated with the volume of the cholinergic basal forebrain in aMCI individuals
André, C., Martineau‐Dussault, M., Daneault, V., Blais, H., Frenette, S., Lorrain, D., Hudon, C., Bastien, C., Petit, D., Lafrenière, A., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01265-y · Cited by 28
ZAHER, M. S. M. A. B. M. A. F., & ALY, A. S. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.93997 · Cited by 28
Thakur, A., Sharma, B., Parashar, A., Sharma, V., Kumar, A., & Mehta, V. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2192805 · Cited by 28
Acetylcholinesterase Inhibition and Antioxidant Activity Properties of Petiveria Alliacea L
Zavala-Ocampo, L. M., Aguirre-Hernández, E., López-Camacho, P. Y., Cárdenas-Vázquez, R., Dorazco‐González, A., & Basurto‐Islas, G. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115239 · Cited by 27
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 27
Hautecloque, G., Sellal, F., Bousiges, O., Phillipi, N., Blanc, F., & Cretin, B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221197 · Cited by 27
Zameer, S., Alam, M. M., Hussain, S., Vohora, D., Ali, J., Najmi, A. K., & Akhtar, M. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.010 · Cited by 27
Myrtus communis subsp. communis improved cognitive functions in ovariectomized diabetic rats
Yaman, B. K., Çevik, Ö. D., Yalman, K., Ertaş, B., Şen, A., & Şener, G. (2020) · Gene · doi:10.1016/j.gene.2020.144616 · Cited by 27
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 27
Xia, J., Dong, S., Yang, L., Wang, F., Xing, S., Du, J., & Li, Z. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106980 · Cited by 27
Application of Optogenetics in Neurodegenerative Diseases
Zhang, Q., Li, T., Xu, M., Islam, B., & Wang, J. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01486-1 · Cited by 27
Alcantara‐Gonzalez, D., Chartampila, E., Criscuolo, C., & Scharfman, H. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105274 · Cited by 27
de Oliveira, J., Moreira, E. L. G., & Bem, A. F. D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102149 · Cited by 27
Nagori, K., Pradhan, M., & Nakhate, K. T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150925 · Cited by 27
Park, S. K., Kang, J. Y., Kim, J. M., Kim, H., & Heo, H. J. (2021) · Marine Drugs · doi:10.3390/md19030131 · Cited by 27
Tian, D., Zhang, W., Lu, L., Yu, Y., Yu, Y., Zhang, X., Li, W., Shi, W. M., & Liu, G. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.141971 · Cited by 27
Altered heart rate variability during sleep in mild cognitive impairment
Kong, S. D., Hoyos, C. M., Phillips, C. L., McKinnon, A. C., Lin, P., Duffy, S. L., Mowszowski, L., LaMonica, H. M., Grunstein, R. R., Naismith, S. L., et al. (2020) · SLEEP · doi:10.1093/sleep/zsaa232 · Cited by 27
McNerney, M. W., Heath, A. M., Narayanan, S., & Yesavage, J. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215361 · Cited by 27
Teniou, S., Benseguenı, A., Hybertson, B. M., Gao, B., Bose, S. K., McCord, J. M., Chovelon, B., Bensouıcı, C., Boumendjel, A., & Hininger‐Favier, I. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104965 · Cited by 27
Ameliorative effect of myrcene in mouse model of Alzheimer's disease
Kumar, R., Kumar, R., Sharma, N., & Khurana, N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174529 · Cited by 27
Chen, J., Hao, W., Zhang, C., Cui, M., Sun, Y., Zhang, Y., Wang, J., Mou, T., Gu, S., Zhao, T., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6362617 · Cited by 27
Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target
Gao, F., Liu, T., Tuo, M., & Chi, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136247 · Cited by 26
Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 26
Chen, C.-W., Kwok, Y., Cheng, Y., Huang, Y., Kuo, T. B. J., Wu, C.-H., Du, P.-J., Yang, A. C., & Yang, C. C. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-38214-6 · Cited by 26
Early-Stage Alzheimer’s Disease Does Not Alter Pupil Responses to Colored Light Stimuli
Kawasaki, A., Ouanes, S., Crippa, S. V., & Popp, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200120 · Cited by 26
Lisgaras, C. P., & Scharfman, H. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106294 · Cited by 26
α7 nicotinic acetylcholine receptor in memory processing
Pastor, V. E., & Medina, J. H. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15913 · Cited by 26
Ojo, A. B., Gyebi, G. A., Alabi, O. O., Iyobhebhe, M. E., Kayode, A. B., Nwonuma, C. O., & Ojo, O. A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133675 · Cited by 26
Binding mechanism and antagonism of the vesicular acetylcholine transporter VAChT
Ma, Q., Ma, K., Dong, Y., Meng, Y., Zhao, J., Li, R., Bai, Q., Wu, D., Jiang, D., Sun, J., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01462-9 · Cited by 26
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 25
Tracing the Path between Mushrooms and Alzheimer’s Disease—A Literature Review
Silva, A. M., Preto, M., Grosso, C., Vieira, M., Delerue-Matos, C. M., Vasconcelos, V. M., Reis, M. A., Barros, L., & Martins, R. F. (2023) · Molecules · doi:10.3390/molecules28145614 · Cited by 25
Reho, P., Kalia, V., Jackson, G. L., Wang, F., Eiten, E., Brennan, K. J. M., Brickman, A. M., Mayeux, R. P., Miller, G. W., Vardarajan, B. N., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70050 · Cited by 25
Molecular Therapeutics in Development to Treat Alzheimer’s Disease
Tartaglia, M. C., & Ingelsson, M. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00738-6 · Cited by 25
Jiménez, M. T. B., Rivas‐García, L., Sánchez‐González, C., Grosso, G., Lipari, V., Ramírez, L. V., Battino, M. A., Giampieri, F., Quiles, J. L., & Forbes-Hernández, T. Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110631 · Cited by 25
Zhang, F., Guo, L., Shi, J., Jiang, H., Zhou, F., Zhou, Y., Lv, B., & Xu, M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106390 · Cited by 25
Betts, G., Hynes, T. J., & Winstanley, C. A. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120972421 · Cited by 25
Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice
Jing, S., Wang, X., Zhang, Z., Cao, D., Huang, K., Wang, Y., Liu, Z., Su, S., & Wang, Q. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01250-2 · Cited by 25
Mitra, S., Khatri, S., Maulik, M., Bult‐Ito, A., & Schulte, M. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144918 · Cited by 25
Olajide, O. J., Rue, C. L., Bergdahl, A., & Chapman, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.960314 · Cited by 25
Melatonin in Alzheimer’s Disease: Literature Review and Therapeutic Trials
Steinbach, M. J., & Denburg, N. L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230760 · Cited by 25
Budvytytė, R., & Valinčius, G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220434 · Cited by 25
Li, W., Wang, Y., Lohith, T. G., Zeng, Z., Tong, L., Mazzola, R., Riffel, K. A., Miller, P. J., Purcell, M. L., Holahan, M. A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg3684 · Cited by 25
Sun, F., Zhao, J. J., Zhang, H., Shi, Q., Liu, Y., Robert, A., Liu, Q., & Meunier, B. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00455 · Cited by 25
Zheng, Y., Fan, L., Fang, Z., Liu, Z., Chen, J., Zhang, X., Wang, Y., Zhang, Y., Jiang, L., Chen, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113073 · Cited by 25
Pérez-Fernández, C., Morales‐Navas, M., Guardia-Escote, L., Colomina, M. T., Giménez, E., & Sánchez-Santed, F. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113356 · Cited by 25
A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures
Rajabian, A., Hosseini, A., Hosseini, M., & Sadeghnia, H. R. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.4.363 · Cited by 25
Cognitive effects of individual anticholinergic drugs: a systematic review and meta-analysis
Naseri, A., Sadigh‐Eteghad, S., Sahebari, S. S., Hosseini, M., Hajebrahimi, S., & Salehi‐Pourmehr, H. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-0053 · Cited by 25
Shafqat, O., Rehman, Z., Shah, M. M., Ali, S. H. B., Jabeen, Z., & Rehman, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110291 · Cited by 25
Xie, M., Gu, S., Hong, Y., Liu, Y., Rong, X., Lu, W., Liu, H., Algradi, A. M., Naseem, A., Shu, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116392 · Cited by 24
Li, K., Mo, D., Yu, Q., Feng, R., & Li, Y. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240505 · Cited by 24
Hoang, K., Watt, H., Golemme, M., Perry, R. J., Ritchie, C. W., Wilson, D., Pickett, J., Fox, C., Howard, R. J., & Malhotra, P. (2022) · Trials · doi:10.1186/s13063-022-06190-3 · Cited by 24
Jia, C., Chai, J., Zhang, S., Sun, Y., He, L., Sang, Z., Chen, D., & Zheng, X. (2025) · Marine Drugs · doi:10.3390/md23030091 · Cited by 24
Zhang, L., Bai, Y., Hong, Z.-S., Xie, J. C., & Tian, Y. (2023) · Nutrients · doi:10.3390/nu15184085 · Cited by 24
Maiuolo, J., Costanzo, P., Masullo, M., D'Errico, A. A., Nasso, R., Bonacci, S., Mollace, V., Oliverio, M., & Arcone, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713461 · Cited by 24
Séguy, L., Groo, A., & Malzert‐Fréon, A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.022 · Cited by 24
Small intestinal bacterial overgrowth in Alzheimer’s disease
Kowalski, K., & Mulak, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02440-x · Cited by 24
Chavan, R. S., Supalkar, K. V., Sadar, S. S., & Vyawahare, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148449 · Cited by 24
Shi, Y., Zhang, H., Song, Q., Yu, G., Liu, Z., Zhong, F., Tan, Z., Liu, X., & Deng, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114098 · Cited by 24
Cao, S., Aman, Y., Fang, E. F., & Tencomnao, T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02904-5 · Cited by 24
Photobiomodulation for Hypertension and Alzheimer’s Disease
Valverde, A., & Mitrofanis, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220632 · Cited by 24
Ding, Y., He, J., Kong, F., Sun, D., Chen, W., Luo, B., Wu, J., Zhang, S., Zhan, P., & Peng, C. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230171 · Cited by 24
Nilofar, N., Zengin, G., Uba, A. İ., Abul, N., Gülçın, İ., Koyuncu, İ., Yüksekdağ, Ö., Ponniya, S. K. M., Tessappan, S., Nazzaro, F., et al. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105088 · Cited by 24
García-Marín, I. D., Camarillo-López, R. H., Martínez, O. A., Martínez, I. I. P., Correa‐Basurto, J., & Rosales‐Hernández, M. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269129 · Cited by 24
Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
Li, S., Hou, Z., Ye, T., Song, X., Hu, X., & Chen, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1431894 · Cited by 23
Metadata
- Authors
- Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., & Khachaturian, Z. S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Northwestern University (US)
- McGill University (CA)
- Indiana University School of Medicine (US)
- University Hospital of Geneva (CH)
- Saint Louis University (US)
- Prevent Alzheimer’s Disease 2020 (US)
- University of Rhode Island (US)
- Corresponding author
- Hampel, Harald
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-05-29
- Volume
- 141
- Issue
- 7
- Pages
- 1917-1933
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6022632
- OpenAlex
- W2805257646
- Cited by
- 1,918
- References
- 179
- Citations by year
- 2026: 245 · 2025: 298 · 2024: 298 · 2023: 328 · 2022: 300 · 2021: 228 · 2020: 130 · 2019: 65 · 2018: 21
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Funders
- AXA Research Fund
- ‘Fondation pour la Recherche sur Alzheimer’, Paris, France. Ce travail a bénéficié d'une aide de l’Etat ‘Investissements d’avenir’ (ANR-10-IAIHU-06)
- ‘Investissements d’avenir’ (ANR-10-IAIHU-06)
- Canadian Institutes of Health Research
- National Research Council
- Alzheimer Society of Canada
- Rotary Club Livorno ‘Mascagni’/The Rotary Foundation (GG1758249)
- ADC (AG013854)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, cholinergic system, cholinergic hypothesis, cholinesterase inhibitors, acetylcholine, cholinergic denervation, neurofibrillary degeneration, amyloid plaques, cognitive decline, cholinergic drugs, combination therapy
- MeSH terms
- Alzheimer Disease, Cholinesterase Inhibitors, Cognition, Cognition Disorders, Humans, Amyloid beta-Peptides, Neurofibrillary Tangles, Cholinergic Agents, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.